Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 3084503)

Published in Transfusion on August 30, 2010

Authors

Meytal Landau1, Nurit Rosenberg

Author Affiliations

1: Amalia Biron Research Institute of Thrombosis and Hemostasis, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

Articles cited by this

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47

MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res (2004) 168.89

The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1999. Nucleic Acids Res (1999) 39.32

Integrins: bidirectional, allosteric signaling machines. Cell (2002) 36.25

The Universal Protein Resource (UniProt). Nucleic Acids Res (2005) 23.66

SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformatics (2006) 21.54

Hidden Markov models. Curr Opin Struct Biol (1996) 11.56

ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res (2005) 10.60

SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res (2007) 8.46

Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science (2001) 8.12

Site-specific evolutionary rate inference: taking phylogenetic uncertainty into account. J Mol Evol (2005) 7.00

Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature (2004) 5.87

Structural basis of collagen recognition by integrin alpha2beta1. Cell (2000) 4.84

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med (1996) 3.72

Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell (2008) 3.54

ConSeq: the identification of functionally and structurally important residues in protein sequences. Bioinformatics (2004) 3.50

Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling. Proteins (2003) 3.04

Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation (2000) 1.91

Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3. J Cell Biol (2008) 1.83

Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. Proc Natl Acad Sci U S A (2004) 1.81

Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem (2004) 1.76

Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Science (2003) 1.65

Nomenclature of human platelet antigens. Vox Sang (2003) 1.62

Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation. Science (2003) 1.57

Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells. Blood (2009) 1.45

Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol (1999) 1.33

Mutagenesis-based definitions and probes of residue burial in proteins. Proc Natl Acad Sci U S A (2005) 1.17

Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. FASEB J (2006) 1.15

New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia. Transfusion (2009) 1.07

Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion (2004) 1.05

A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia. Blood (2002) 0.99

Binding of platelet glycoprotein Ibbeta through the convex surface of leucine-rich repeats domain of glycoprotein IX. J Thromb Haemost (2009) 0.97

Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response. Blood (1995) 0.95

Key interactions in integrin ectodomain responsible for global conformational change detected by elastic network normal-mode analysis. Biophys J (2008) 0.94

Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3. Thromb Haemost (2007) 0.92

Human platelet alloantigens: recent findings, new perspectives. Thromb Haemost (1995) 0.89

Human platelet antigen 3 (HPA-3): localization of the determinant of the alloantibody Lek(a) (HPA-3a) to the C-terminus of platelet glycoprotein IIb heavy chain and contribution of O-linked carbohydrates. Thromb Haemost (1993) 0.88

Platelet glycoprotein IIb/IIIa polymorphism and coronary artery disease: implications for clinical practice. Am J Pharmacogenomics (2005) 0.86

A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation. J Thromb Haemost (2004) 0.86

A naturally occurring LeuVal mutation in beta3-integrin impairs the HPA-1a epitope: the third allele of HPA-1. Transfusion (2006) 0.86

HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope. Blood (2002) 0.86

A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens. Blood (2002) 0.86

A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet beta 3 integrin subunit. The Sra alloantigen system of GPIIIa. J Biol Chem (1994) 0.84

Molecular mechanisms of prothrombotic risk due to genetic variations in platelet genes: Enhanced outside-in signaling through the Pro33 variant of integrin beta3. Exp Biol Med (Maywood) (2006) 0.84

Three novel beta3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency beta3-HPA antibodies. J Thromb Haemost (2007) 0.84

Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia. Haematologica (2007) 0.84

Trp207Gly in platelet glycoprotein Ibalpha is a novel mutation that disrupts the connection between the leucine-rich repeat domain and the disulfide loop structure and causes Bernard-Soulier syndrome. J Thromb Haemost (2006) 0.83

Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin (ITGA2B, ITGB3). Hum Mutat (2006) 0.81

A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope. Blood (1991) 0.81

Structural biology. A ménage à trois in two configurations. Science (2003) 0.76

Articles by these authors

Thrombophilia does not increase risk for neonatal complications in preterm infants. Thromb Haemost (2003) 1.54

The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction. Am J Obstet Gynecol (2004) 1.44

Specific cysteines in beta3 are involved in disulfide bond exchange-dependent and -independent activation of alphaIIbbeta3. J Biol Chem (2008) 1.04

Spectrum of the mutations in Bernard-Soulier syndrome. Hum Mutat (2014) 0.97

Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3. Thromb Haemost (2007) 0.92

Unique disulfide bonds in epidermal growth factor (EGF) domains of β3 affect structure and function of αIIbβ3 and αvβ3 integrins in different manner. J Biol Chem (2012) 0.90

Post-transfusion purpura--when and why? Isr Med Assoc J (2006) 0.88

Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood (2002) 0.85

Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombasthenia. Haematologica (2007) 0.84

High prevalences of vitamin B12 and folic acid deficiency in elderly subjects in Israel. Br J Haematol (2003) 0.84

Nonarteritic anterior ischemic optic neuropathy is associated with a specific platelet polymorphism located on the glycoprotein Ibalpha gene. Ophthalmology (2004) 0.83

Upregulation of osteoclast alpha2beta1 integrin compensates for lack of alphavbeta3 vitronectin receptor in Iraqi-Jewish-type Glanzmann thrombasthenia. Br J Haematol (2003) 0.83

Role of five platelet membrane glycoprotein polymorphisms in branch retinal vein occlusion. Blood Coagul Fibrinolysis (2006) 0.81

A mutation in LMAN1 (ERGIC-53) causing combined factor V and factor VIII deficiency is prevalent in Jews originating from the island of Djerba in Tunisia. Blood Coagul Fibrinolysis (2004) 0.81

Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin (ITGA2B, ITGB3). Hum Mutat (2006) 0.81

The impact of genetic and environmental factors on homocysteine levels in preterm neonates. Pediatr Blood Cancer (2012) 0.80

A unique interaction between alphaIIb and beta3 in the head region is essential for outside-in signaling-related functions of alphaIIbbeta3 integrin. Blood (2010) 0.80

Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia. Transfusion (2012) 0.78

Of four mutations in the factor VII gene in Tunisian patients, one novel mutation (Ser339Phe) in three unrelated families abrogates factor X activation. Blood Coagul Fibrinolysis (2005) 0.78

Abnormal cytoplasmic extensions associated with active αIIbβ3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome. Blood Coagul Fibrinolysis (2015) 0.78

Unbalanced protein S deficiency due to warfarin treatment as a possible cause for thrombosis. Br J Haematol (2007) 0.78

Antiplatelet effect of thienopyridine (clopidogrel or prasugrel) pretreatment in patients undergoing primary percutaneous intervention for ST elevation myocardial infarction. Am J Cardiol (2013) 0.77

A novel ancestral splicing mutation in the multidrug resistance protein 2 gene causes Dubin-Johnson syndrome in Ashkenazi Jewish patients. Hepatol Res (2005) 0.77

Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia. Br J Haematol (2013) 0.77

Effect of four missense mutations in the factor XIII A-subunit gene on protein stability: studies with recombinant proteins. Blood Coagul Fibrinolysis (2006) 0.77

Thrombophilic state in young patients with acute myocardial infarction. J Thromb Thrombolysis (2015) 0.77

Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations. Blood Coagul Fibrinolysis (2007) 0.75

A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa. Thromb Haemost (2005) 0.75

The influence of prothrombotic polymorphisms and obstetrical and medical variables on the length of secondary postpartum hemorrhage. J Womens Health (Larchmt) (2005) 0.75

Natural and artificial mutations in αIIb integrin lead to a structural deformation of a calcium-binding site. Protein J (2014) 0.75

Evaluation of platelet response to different clopidogrel dosing regimens in patients with acute coronary syndrome in clinical practice. Platelets (2014) 0.75

Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding. Thromb Res (2009) 0.75

Surfactant impairs coagulation in-vitro: a risk factor for pulmonary hemorrhage? Thromb Res (2013) 0.75